featured
Minimal Residual Disease as a Predictor of Survival in Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Minimal Residual Disease in Myeloma by Flow Cytometry: IndependentPrediction of Survival Benefit per Log Reduction
Blood 2015 Mar 19;125(12)1932-1935, AC Rawstron, WM Gregory, RM de Tute, FE Davies, S Bell, MT Drayson, G Cook, GH Jackson, GJ Morgan, JA Child, RG OwenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.